Objective: Interpregnancy interval (IPI) influences numerous adverse perinatal outcomes. IPI's impact on birth defects is unclear.
Introduction
Birth defects are conditions, which include a malformation, deformation or disruption in one or more parts of the body, are present at birth and have a serious adverse effect on health, development and/or functional ability. During the last decade in the United States, birth defects are among the leading causes of pediatric hospitalizations, medical expenditures and infant mortality, accounting for more than 20% of all infant deaths. [1] [2] [3] Approximately 3% of all infants born in the United States, or about 120 000 babies annually, are born with a major birth defect, and annually, about 8000 of these infants die during their first year of life. 4 In addition, birth defects are the fifth leading cause of years of potential life lost and contribute substantially to childhood morbidity and long-term disability. A broad spectrum of factors, which range from maternal health conditions (such as maternal diabetes, smoking and use of alcohol or nutritional deficiencies) to environmental conditions (such as pollutants, occupational hazards, dietary factors, medications or certain personal behaviors) to genetic/chromosomal anomalies have been described as causes or contributors of birth defects. 5 However, an estimated 50 to 60% of birth defects do not have an attributable cause. 4 One potential contributor to giving birth to infants with birth defects is interpregnancy interval (IPI), defined as the period between a live birth and the conception of a subsequent fetus. A meta-analysis showed that a short IPI (<6 months) was associated with a 40% increased risk for preterm birth, a 60% increased of LBW and 25% increased risk of SGA. 6 Other studies have observed that a shorter IPI (<6 months) is also associated with additional adverse birth outcomes, including premature rupture of membranes, 7 miscarriage, 8 spontaneous abortion 9 and fetal loss. 10 Alternatively, studies have suggested that an IPI between 18 to 23 months is in general associated with the lowest risks of adverse perinatal outcomes. 6, 7, 11 However, the impact of IPI on birth defects has been understudied. One study that has evaluated the effect of IPI on major birth defects is an Israeli cohort study. In this cohort, an IPI less than 6 months was associated with a 14% increased risk of major malformations.
12 A possible biological explanation by which IPI could result in birth defects is the association of this period with an 'insufficient recovery interval,' leading to an inadequate repletion of nutritional factors and normal homeostasis. For example, mothers with a short IPI, who have not completely recovered from a former pregnancy and shortly become pregnant, are more likely to develop folate deficiency. 13, 14 The association between folate deficiency and neural tube defects has been well-described. Moreover, during the IPI, other events such as breastfeeding or major weight changes may take place, which also affect the mother's nutritional status and normal homeostasis. 15, 16 However, this could also be a chance finding, as no studies have yet attempted to replicate its results. To further explore this relationship, we conducted a study on the association between IPI and birth defects, using a population-based case-control study design.
Methods
This population-based case-control study utilized data from Washington State birth certificates of singleton infants, born between the years 1998 and 2008, and hospitalization data from the state's Comprehensive Hospital Abstract Reporting System (CHARS). CHARS is organized by the Washington State Department of Health and contains inpatient discharge data of hospitals throughout Washington State. CHARS data have been used in many different epidemiologic studies to evaluate a range of birth defects. [17] [18] [19] [20] Women were eligible for this study if they gave birth to two singleton infants between 1998 and 2008. Women whose first or second birth involved a multiple birth were excluded. This study was approved by the University of Washington Institutional Review Board.
Cases were defined as women whose second of these two births resulted in a singleton infant, with one or more birth defects. Three times as many controls, women, whose second birth resulted in an infant without a birth defect, were frequency matched to cases on age at second birth. Infants with a birth defect were identified through check-box information recorded on their birth certificate and through ICD-9 codes on their CHARS hospital discharge record (using ICD-9 codes 740 to 759). As birth certificates may only capture obvious anatomical defects seen at birth, cases were women whose infant was identified as having a birth defect according to birth certificates and/or CHARS data. A total of 10 772 cases and 32 316 controls were identified. However, two cases and six controls did not have adequate information to calculate IPI and were excluded, leaving a final sample size of 10 770 cases and 32 310 controls.
Birth defects were classified into 10 groups with similar characteristics based on ICD-9 codes: central nervous system defects (that is, anencephalus, spina bifida and so on; 740.0 to 742.9), eye and ear defects (743.0 to 744.9), cardiovascular defects (such as bulbus cordis anomalies or abnormal closure of the cardiac septum; 745.0 to 747.9), respiratory anomalies (748.0 to 748.9), cleft lip and cleft palate (749.0 to 749.2), gastrointestinal anomalies (750.0 to 751.9), genitourinary anomalies (divided in anomalies of the genital organs and anomalies of the urinary system; 752.0 to 753.9), musculoskeletal (anomalies or deformities; 754.0 to 756.9), chromosomal anomalies (758.0 to 758.9) and a final group labeled as 'other' for anomalies of the integument and unspecified congenital anomalies (757.0 to 757.9, 759.0 to 759.9). 21 Our exposure of interest was IPI, which we defined as the period between delivery of a first pregnancy and the conception of a subsequent one, calculated as the interval between two consecutive deliveries minus the gestational age of the second infant. This definition is consistent with earlier studies that have evaluated IPI. 6, 11 Dates of first and second births and the gestational ages of second infants were all obtained from birth certificate data. In our analysis, we treated IPI as a categorical variable, dividing it into the following five categories: 0 to 5 months, 6 to 11 months, 12 to 17 months, 18 to 23 months, 25 and 59 months and 60 months or beyond. The interval of 18 to 23 months was selected as the reference category for our analyses on the basis of work of previous studies, indicating that mothers with this IPI had lower risks of adverse perinatal events. 6, 11 The risks estimates for giving birth to an infant with birth defects per IPI categories were assessed using unconditional logistic regression. All analyses were carried out using Stata version 10.1 for Windows (TX, USA), and all statistical models were adjusted for maternal age at second birth (<20, 20 to 24, 25 to 29, 30 to 34, 35 þ years), as this was a matching factor. Variables considered as potential confounders and/or effect modifiers included: mother's parity at second birth, marital status, education level, maternal race, mother's body mass index, Kotelchuck Index, paternal age (<20, 20 to 29, 30 to 39, 40 þ years), sex of the second infant, change in paternity. These variables correspond to the second birth. We also considered characteristics of the first infant, such as preterm birth and low birth weight, and history of a previous infant with birth defect. None of the potential confounders changed our risk estimates by greater than 10% when evaluated and were thus not included in our final multivariate model based on the 'change in estimate' strategy. 22 Maternal age, marital status, education, change in paternity, history of a previous infant with birth defects, preterm birth, infant sex and low birth weight were considered as potential effect modifiers. Effect modification was assessed using the Breslow-Day test for homogeneity. No statistically significant interactions with any of these potential effect modifiers assessed were observed.
Results
Cases and controls were generally similar with respect to maternal and other characteristics, including age at second birth, education, body mass index, urban versus rural residence, Kotelchuck Index, paternal age and frequency of change in paternity. Cases were somewhat more likely than controls to be non-White and to be unmarried. With respect to characteristics of the first infants, cases were somewhat more likely to have had a first infant who was born preterm, with a low birth weight or with a history of some type of birth defect. The second infants of cases were somewhat more likely to be male compared with controls ( Table 1) .
The risk of giving birth to an infant with a birth defect according to IPI had a J-shaped association (if months on the figure are drawn to scale), with the highest risks observed at the shortest and longest IPIs (Figure 1) . Specifically, compared with women with an IPI between 18 to 23 months, those with an IPI of <6 months or X60 months each had a 15% increased risk of having an infant with a birth defect, whereas those with an IPI of 6 to 11 months or 24 to 59 months had a 9% increased risk (Table 2) . With respect to specific birth defects, an IPI <6 months was associated with an increased risk of cardiovascular system birth defects (odds ratio 1.32; 95% confidence interval 1.07 to 1.64) ( Table 3 ). An IPI of >60 months was associated with 1.28 to 2.28-fold increase risks of an infant with cardiovascular birth defect, central nervous system birth defect and chromosomal anomalies. Discussion IPI has been studied extensively, with respect to its associations with various adverse perinatal outcomes, including low birth weight, preterm birth, small for gestational age and early neonatal death. However, there is a lack of data on IPI's association with birth defects, with only one previous study having evaluated this 
Figure 1 Odds ratios for birth defect with 95% confidence interval ranges (adjusted for maternal age) plotted against interpregnancy interval (IPI).
Interpregnancy interval and birth defects in Washington State S Kwon et al relationship. 12 Consistent with this earlier Israeli study, in this first United States population-based study, we observed a J-shaped relationship between IPI and birth defects. Infants born following either a shorter IPI (<6 months) or longer IPI (>60 months) had a 15% increased risk of a birth defect. In the Israeli study, they found that a short IPI (<6 months) was associated with a 20% increased risk of having an infant with a birth defect and that a long IPI (60 þ months) was associated with a 31% increased risk. With respect to specific types of birth defects, in our study, a short IPI was only associated with cardiovascular birth defects, whereas a long IPI was associated with central nervous system, cardiovascular system and chromosomal anomalies.
The adverse consequences of a short IPI have been attributed to biological effects: maternal depletion syndrome and post partum stress. 23 During this period, mothers may not be able to completely recover from a previous pregnancy in terms of folate, vitamin B12 and other micronutrient reserves; therefore, a minimal time may be needed for the mothers' nutritional recovery. Studies of folate in relation to adverse birth outcomes other than birth defects, like fetal growth restriction, suggest that folate depletion contributes to them. [24] [25] [26] There is scant literature on potential mechanisms through which other diverse factors like hormones, nutrients, behavior and psychosocial characteristics may influence risk of birth defects. With respect to cardiovascular birth defects specifically, factors influencing the development of the cardiovascular system include environmental conditions (maternal conditions and /or infections, exposure to teratogens or chemicals) and genetic factors. 27 Han et al. 28 found that, in vertebrate animal models, a higher level of folic acid supplementation could prevent cardiac defects, but the biological basis for this remains unclear. So a relative inability to fully restore folate stores among mothers with a short IPI could potentially explain their greater risk of having an infant with a cardiovascular birth defect.
Long IPIs (>24 months), particularly longer than 60 months, have also been shown to be associated with an increased risk of birth defects. Again though, little is known about the underlying biological mechanisms. With longer IPIs, women are likely older, may have more health problems or may have not been able to get pregnant easily (delayed pregnancy). However, controls were matched to cases on maternal age, and maternal age was also not found to be an effect modifier. There have been two hypotheses put forth to potentially explain the relationship between long IPIs and adverse perinatal outcomes. One is that, 'growth-supporting Abbreviations: CI, confidence intervals; IPI, interpregnancy interval; OR, odds ratio. The odds ratios were adjusted for maternal age. a There were 10 806 total birth defects and 10 772 infants with at least birth defects. The percentage is obtained using total birth defects as the denominator. Interpregnancy interval and birth defects in Washington State S Kwon et al capacities' decline in between pregnancies with longer IPIs, and the other is that, there may be unmeasured metabolic or anatomical factors that cause both delayed fertility and adverse perinatal outcomes simultaneously. 11 We found birth defects for central nervous system, cardiovascular system and chromosomal anomalies to be specifically related to long IPIs. Given the two hypotheses, it may be that there are specific unknown factors associated with delayed fertility and long IPI that influence the development of the cardiovascular and central nervous systems and the frequency of chromosomal anomalies. With respect to chromosomal anomalies, the association between advanced maternal age and increased risk of chromosomal abnormalities has been well documented in the past, 29, 30 but we saw an increased risk of chromosomal abnormality that was independent of maternal age. It has been hypothesized that chromosomal defects occur with older age, secondary to inferior quality of egg cells either due to progressive deterioration with age or due to 'higher quality' egg cells being selected first for maturation earlier in age. [31] [32] [33] So, it is possible that the increased risk of chromosomal abnormalities may be related to a longer 'waiting period' between pregnancies that leads to progressive deterioration of egg cells or to selection from more 'inferior' quality groups of egg cells.
Although use of administrative data provides us with a large sample size, there are limitations to use of these types of data. The definition and/or availability of certain variables considered to be possible potential confounders and effect modifiers may be limited. For example, we did not have detailed data on maternal breastfeeding, which can have an important role when considering nutritional deficiency in the context of the relationship between IPI and birth defects. We also did not have information regarding the severity of birth defects or subsequent clinical outcomes. There is also a risk of misclassification bias with IPI, birth defects and clinical characteristics of mothers and infants. To avoid these problems, we used both birth certificates and CHARS data, linking them to identify our IPIs, birth defects and other covariates. By linking the two datasets together, we were able to expand the availability of clinical information on both cases and controls. Also, the linked dataset mitigated misclassification of our outcome. For example, birth certificates would capture more obvious birth defects, whereas CHARS data would capture most of other clinically important and detectable birth defect during the infant's hospitalization. By linking the two together, we were able to collect information on all clinically detectable birth defects along with other variables. Lastly, we were not able to evaluate pregnancies that did not result in a live birth, and so, to the extent that IPI length is associated with likelihood of pregnancy termination or a spontaneous abortion, the results seen here could be biased either toward or away from the null. For example, if women with the reference IPI of 18 to 23 months were more likely to present in time for an antenatal visit, undergo screening procedures and elect to carry to term only if there were no birth defects compared with women with other IPIs, the true incidence of anomalies in this group would be underestimated. Although the extent of this potential problem is not assessable in our data, this effect would need to be quite pronounced to alone fully account for the J-shaped relationship observed.
Birth defects are a major problem contributing to a large proportion of infant mortality, years of potential life lost before age 65 and significant medical resource use and costs. [1] [2] [3] Around 50 to 60% of birth defects do not have an attributable cause. [1] [2] [3] This is the first US population-based study to document a potential new risk factor for birth defects, IPI. This relationship certainly requires further replication, but if confirmed, could offer new insights into biological mechanisms contributing to the etiology of different types of birth defects.
